SCHEMBL2074533

SCHEMBL2074533

COC(=O)c1cc2c([nH]1)CCC2=Cc1ccc(C)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
GAA P10253 3/20 0.36
HTT P42858 1/20 0.36
CYP1A2 P05177 3/20 0.34
CYP2C9 P11712 3/20 0.34
MAPK1 P28482 2/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP3A4 P08684 2/20 0.34
XDH P47989 1/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
ATM Q13315 1/20 0.34
ALDH1A1 P00352 2/20 0.34
ABL1 P00519 2/20 0.34
SRC P12931 2/20 0.34
PLIN1 O60240 1/20 0.34
LMNA P02545 1/20 0.34
PLIN5 Q00G26 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074532 1.00 MAPT (0.36) MAPTMEN1KMT2AGAAHTT
SCHEMBL2074531 1.00 MAPT (0.36) MAPTMEN1KMT2AGAAHTT
SCHEMBL2075600 0.85 MAPT (0.53) MAPTMEN1KMT2AGAAHTT
SCHEMBL2075602 0.85 MAPT (0.53) MAPTMEN1KMT2AGAAHTT
SCHEMBL2076165 0.85 MAOA (0.42) MAPTMEN1KMT2ACYP1A2CYP2C9
SCHEMBL2076158 0.85 MAOA (0.42) MAPTMEN1KMT2ACYP1A2CYP2C9
SCHEMBL2075603 0.85 MAPT (0.53) MAPTMEN1KMT2AGAAHTT
SCHEMBL2076160 0.85 MAOA (0.42) MAPTMEN1KMT2ACYP1A2CYP2C9
SCHEMBL1002792 0.85 MAOA (0.40) MAPTMEN1KMT2AGAAHTT
SCHEMBL1002794 0.85 MAOA (0.40) MAPTMEN1KMT2AGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE MAPT 444/4885MEN1 4856/4885KMT2A 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.